ENVB
Enveric Biosciences, Inc.
$1.75
-2.78%
$6.4M
No data for this timeframe.
Vol
Market Cap$6.4M
Cap SizeNano Cap
Inst. Holders2 funds
Inst. Value$22.00
Reddit Sentiment67° Warm
SEC Reports6
Recent Activity
Jun 9, 2026
SEC
Enveric Biosciences filed a prospectus supplement to offer up to $2,425,000 of common stock under its existing ATM agree
8-K — Impact 6/10
Jun 9, 2026
SEC
Enveric Biosciences filed a 424B5 prospectus supplement to increase its ATM offering capacity by up to $2,425,000, bring
424B5 — Impact 7/10
Jun 1, 2026
Insider
Coveney Kevin Michael sold 133,333 shares
Chief Financial Officer @ $0.00 ($0.00)
Jun 1, 2026
Insider
Tucker Joseph Edward sold 201,124 shares
Chief Executive Officer @ $0.00 ($0.00)
Jun 1, 2026
Insider
PASQUALONE FRANK sold 18,518 shares
Director @ $0.00 ($0.00)
May 29, 2026
SEC
Enveric Biosciences filed an 8-K reporting two routine items: (1) the Compensation Committee approved new forms of RSU a
8-K — Impact 6/10
May 13, 2026
earnings_calendar
ENVB Q1 2026 Earnings Scheduled — 2026-05-13
Analyst Ratings
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Mar 6, 2025 | HC Wainwright & Co. | REITERATE | Buy → Buy |
| Jan 30, 2024 | HC Wainwright & Co. | INITIATE | Buy |
Latest Reports
BEARISH
8-K
6/10
Enveric Biosciences filed a prospectus supplement to offer up to $2,425,000 of common stock under its existing ATM agree
Jun 9, 2026
BEARISH
424B5
7/10
Enveric Biosciences filed a 424B5 prospectus supplement to increase its ATM offering capacity by up to $2,425,000, bring
Jun 9, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BANK OF AMERICA CORP | $18.00 | — |
| WELLS FARGO & COMPANY/MN | $4.00 | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 1, 2026 | Coveney Kevin | A | $0.00 |
| Jun 1, 2026 | Tucker Joseph | A | $0.00 |
| Jun 1, 2026 | PASQUALONE FRANK | A | $0.00 |
| Jun 1, 2026 | DeWitt Sheila | A | $0.00 |
| Jun 1, 2026 | Facchini Peter | A | $0.00 |
Reddit Sentiment
67°
Warm
Bearish
Neutral
Bullish
2 institutional holders with $22.00 total value (6 shares) as of 2025-Q4. Top holders: BANK, WELLS.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BANK OF AMERICA CORP /DE/ | 5 | $18.00 | 81.8% | — |
| 2 | WELLS FARGO & COMPANY/MN | 1 | $4.00 | 18.2% | — |
8 unique insiders with 0 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Coveney Kevin Michael | Chief Financial Officer | A | 133,333 | $0.00 | $0.00 |
| Jun 1, 2026 | Tucker Joseph Edward | Chief Executive Officer | A | 201,124 | $0.00 | $0.00 |
| Jun 1, 2026 | PASQUALONE FRANK | Director | A | 18,518 | $0.00 | $0.00 |
| Jun 1, 2026 | DeWitt Sheila | Director | A | 18,518 | $0.00 | $0.00 |
| Jun 1, 2026 | Facchini Peter J. | Chief Innovation Officer | A | 25,000 | $0.00 | $0.00 |
| Jun 1, 2026 | Kegler George A. | Director | A | 18,518 | $0.00 | $0.00 |
| Jun 1, 2026 | Schabacker Marcus | Director | A | 18,518 | $0.00 | $0.00 |
| Jun 1, 2026 | WEBB MICHAEL D | Director | A | 18,518 | $0.00 | $0.00 |
6 SEC filing reports analyzed. Sentiment: 0 bullish, 4 bearish, 0 mixed, 2 neutral. Avg impact: 5.2/10.
BEARISH
8-K
6/10
Enveric Biosciences filed a prospectus supplement to offer up to $2,425,000 of common stock under it
Jun 9, 2026
BEARISH
424B5
7/10
Enveric Biosciences filed a 424B5 prospectus supplement to increase its ATM offering capacity by up
Jun 9, 2026
BEARISH
8-K
6/10
Enveric Biosciences filed an 8-K reporting two routine items: (1) the Compensation Committee approve
May 29, 2026
NEUTRAL
8-K
4/10
Enveric Biosciences reported Q1 2026 results with a net loss of $1.6M ($1.08 per share) vs $2.2M in
May 15, 2026
BEARISH
S-3
6/10
Enveric Biosciences has filed an S-3 shelf registration to register 6,822,225 shares of common stock
Apr 23, 2026
NEUTRAL
DEFA14A
2/10
Enveric Biosciences, Inc. has filed a definitive proxy statement for its annual shareholder meeting.
Apr 14, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Mar 2025): 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q 2025-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2025-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 1 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Mar 6, 2025 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Jan 30, 2024 | HC Wainwright & Co. | INITIATE | — | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Feb 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Jan 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Dec 1, 2025 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Nov 1, 2025 | 2 | 4 | 1 | 0 | 0 | 86% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
67°
Warm
Bearish
Neutral
Bullish
2 mentions
2 bullish
0 bearish
2 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Apr 20, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Apr 20, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
Recent Reddit Threads
May 13, 2026
earnings_calendar
ENVB Q1 2026 Earnings Scheduled — 2026-05-13
May 12, 2026
earnings_calendar
ENVB Q1 2026 Earnings Scheduled — 2026-05-12
May 5, 2026
short_volume
Short Volume: ENVB — 56.1% short (0.3M / 0.5M)
Short: 282,961 | Exempt: 38,100 | TRF Vol: 504,480 | Short Ratio: 56.1% | Off-exchange volume (dark pool + OTC)
May 1, 2026
short_interest
FTD: ENVB — 346,235 shares ($1.4M) failed to deliver
Settlement: 20260501, Price: $3.95, FTD Value: $1,367,628.25, ENVERIC BIOSCIENCES INC COM OC
Apr 29, 2026
short_interest
FTD: ENVB — 99,193 shares ($0.5M) failed to deliver
Settlement: 20260429, Price: $5.32, FTD Value: $527,706.76, ENVERIC BIOSCIENCES INC COM OC
Apr 28, 2026
short_interest
FTD: ENVB — 111,651 shares ($0.6M) failed to deliver
Settlement: 20260428, Price: $5.10, FTD Value: $569,420.1, ENVERIC BIOSCIENCES INC COM OC
Apr 27, 2026
short_interest
FTD: ENVB — 299,379 shares ($1.5M) failed to deliver
Settlement: 20260427, Price: $5.04, FTD Value: $1,508,870.16, ENVERIC BIOSCIENCES INC COM OC
Apr 24, 2026
short_interest
FTD: ENVB — 435,404 shares ($1.8M) failed to deliver
Settlement: 20260424, Price: $4.02, FTD Value: $1,750,324.08, ENVERIC BIOSCIENCES INC COM OC
Apr 23, 2026
short_interest
FTD: ENVB — 503,975 shares ($1.8M) failed to deliver
Settlement: 20260423, Price: $3.60, FTD Value: $1,814,310, ENVERIC BIOSCIENCES INC COM OC
Apr 22, 2026
short_interest
FTD: ENVB — 576,863 shares ($1.9M) failed to deliver
Settlement: 20260422, Price: $3.37, FTD Value: $1,944,028.31, ENVERIC BIOSCIENCES INC COM OC
Apr 21, 2026
short_interest
FTD: ENVB — 1,175,942 shares ($4.3M) failed to deliver
Settlement: 20260421, Price: $3.65, FTD Value: $4,292,188.3, ENVERIC BIOSCIENCES INC COM OC
Apr 17, 2026
short_volume
Short Volume: ENVB — 68.6% short (0.4M / 0.5M)
Short: 376,422 | Exempt: 37,922 | TRF Vol: 548,409 | Short Ratio: 68.6% | Off-exchange volume (dark pool + OTC)
Apr 16, 2026
short_volume
Short Volume: ENVB — 58.1% short (3.6M / 6.2M)
Short: 3,596,516 | Exempt: 42,507 | TRF Vol: 6,193,394 | Short Ratio: 58.1% | Off-exchange volume (dark pool + OTC)
Mar 26, 2026
earnings_calendar
ENVB Q4 2025 Earnings After Market Close — 2026-03-26